February 9, 2026
 
 
RedChip Logo
Small Stocks, Big Money™
Weekly Newsletter
REDCHIP.COM
 
Feature News
 
Nova Minerals Charts U.S. Redomicile, Targets Full Ownership of Flagship Estelle Project
 
Nova Minerals (Nasdaq: NVA) unveiled plans to redomicile to the United States by mid-2026 while maintaining its dual Nasdaq and ASX listings, a move expected to unlock broader access to lower-cost U.S. capital and institutional investors. As part of the reorganization, the Company intends to acquire the remaining 15% of the Estelle Gold and Critical Minerals Project, positioning Nova with 100% ownership as it advances one of the largest undeveloped gold and antimony projects in the U.S. toward construction and production.
 
 
 
 
 
 
 
 
 
60 Degrees Pharma Expands ARAKODA® Access through GoodRx Partnership
 
60 Degrees Pharmaceuticals (Nasdaq: SXTP) announced a new partnership with GoodRx to broaden access to ARAKODA®, the only FDA-approved, once-weekly malaria prevention therapy in the U.S. The collaboration, which became effective February 2, extends ARAKODA’s reach to over 70,000 pharmacies nationwide, enhancing patient affordability while supporting wider adoption among travelers to malaria-endemic regions and reinforcing the Company’s commercial growth strategy.
 
 
 
 
 
 
 
NioCorp’s Elk Creek Project Aligned with New $12B U.S. Critical Minerals Reserve
 
NioCorp Developments (Nasdaq: NB) praised the White House and the Export-Import Bank of the United States for launching the proposed $12 billion “Project Vault,” a landmark public-private initiative to establish a U.S. Strategic Critical Minerals Reserve. Backed by $11 billion from EXIM and nearly $1.7 billion from major U.S. manufacturers, the program underscores accelerating federal support for domestic critical minerals production—aligning closely with NioCorp’s Elk Creek Project as the Company advances toward supplying U.S.-sourced niobium, scandium, titanium, and potentially rare earths to strengthen American industrial and national security supply chains.
 
 
 
 
 
 
 
 
 
XTI Aerospace Streamlines Portfolio, Divests RTLS Unit to Accelerate Drone and UAS Growth
 
XTI Aerospace (Nasdaq: XTIA) announced the completed sale of its Inpixon RTLS business for approximately $5.5 million, sharpening the Company’s strategic focus on drones, unmanned aircraft systems, and advanced vertical flight technologies. The divestiture reduces operating complexity and costs while allowing XTI to concentrate capital and leadership on scaling its Drone Nerds platform for enterprise and government customers, supporting the Company’s stated path toward sustainable profitability in 2026.
 
 
 
 
 
 
 
Bimergen Energy Targets NYSE American Uplist as It Advances Utility-Scale Battery Storage Platform
 
Bimergen Energy Corporation (OTCQB: BESS) announced that its common stock and warrants are expected to begin trading on the NYSE American on or about February 11, 2026, marking a key milestone in the Company’s evolution as a utility-scale battery energy storage owner and developer. The anticipated uplisting, alongside a concurrent securities offering following SEC effectiveness of its S-1, is expected to enhance capital markets access, visibility, and liquidity as Bimergen continues to build and operate battery storage projects across multiple U.S. power markets.
 
 
 
 
 
Recent News
 
 
 
 
 
 
 
 
 
RedChip TV
 
 
 
 
RedChip Highlights BNB Plus Corp. (NASDAQ: BNBX) & Obook Holdings Inc. (NASDAQ: OWLS)
 
 
 
 
 
 
 
 
From Healthcare SaaS to Nuclear Renaissance: Latest Additions to the RedChip Nation
 
RedChip is pleased to welcome Comprehensive Healthcare Systems (OTCQB: CMHSF | TSXV: CHS) and Foremost Clean Energy (Nasdaq: FMST | CSE: FAT) to the RedChip Nation.
 
Comprehensive Healthcare Systems
(OTCQB: CMHSF | TSXV: CHS)
 
Comprehensive Healthcare is a high-margin SaaS provider serving the $4–6B U.S. healthcare benefits administration market. With its proprietary Novus 360 platform, CMHSF enables over 1 million members annually to access streamlined, automated healthcare and retirement benefits. Backed by 95%+ retention and over C$35M in signed contracts, the company is poised for breakout growth as it targets $100M in total contracts by 2028.
 
Foremost Clean Energy
(NASDAQ: FMST | CSE: FAT)
 
Foremost is one of the only Nasdaq-listed uranium explorers — and it’s not wasting the opportunity. With strategic partnerships, including Denison Mines as its largest shareholder, Foremost controls 10 highly prospective uranium properties in Canada’s world-class Athabasca Basin. Its diversified portfolio also includes lithium and gold projects, positioning the company at the forefront of the clean energy transition.
 
 
Unlock Smarter Investing with RedChat
RedChat Ad
Tired of sifting through endless filings? Let RedChat do the heavy lifting. Get real-time, data-driven insights on over 2,000 small-cap stocks—instantly. Save time, make informed decisions, and stay ahead of the market.
Access RedChat now, free of charge.
START USING REDCHAT
 
Recent Research Coverage Updates
 
Company Rating Price Target Firm Report Date
Enlivex Therapeutics (Nasdaq: ENLV) Buy $13 HC Wainwright January 13, 2026
NioCorp Developments (Nasdaq: NB) Buy $8.7 Freedom Capital Markets January 7, 2026
Gorilla Technology (Nasdaq: GRRR) Buy $31 Cantor Fitzgerald December 11, 2025
NioCorp Developments (Nasdaq: NB) Outperform $12 William Blair November 20, 2025
Alliance Entertainment (Nasdaq: AENT) Buy $11 Noble Capital November 14, 2025
Alliance Entertainment (Nasdaq: AENT) Buy $10 Maxim November 13, 2025
Connect Biopharma (Nasdaq: CNTB) Buy $10 BTIG November 12, 2025
Nova Minerals (Nasdaq: NVA) Buy $50 ThinkEquity October 27, 2025
NioCorp (Nasdaq: NB) Buy $15 Maxim October 15, 2025
NioCorp (Nasdaq: NB) Buy $8 H.C. Wainwright September 22, 2025
Alliance Entertainment (Nasdaq: AENT) Buy $11 Noble Capital October 6, 2025
FibroBiologics (Nasdaq: FBLG) Buy $4 Maxim September 22, 2025
XORTX Therapeutics (Nasdaq: XRTX) Buy $14 AGP September 18, 2025
FibroBiologics (Nasdaq: FBLG) Buy $10 H.C. Wainwright September 12, 2025
Alliance Entertainment (Nasdaq: AENT) Buy $10 Maxim September 11, 2025
FibroBiologics (Nasdaq: FBLG) Buy $16 D Boral September 10, 2025
Greenwich LifeSciences (Nasdaq: GLSI) Buy $45 Noble August 20, 2025
Nexalin Technology (Nasdaq: NXL) Buy $4 Maxim August 19, 2025
Atossa Therapeutics (Nasdaq: ATOS) Buy $7 HC Waingwright August 12, 2025
Atossa Therapeutics (Nasdaq: ATOS) Buy $4 Maxim August 12, 2025
Atossa Therapeutics (Nasdaq: ATOS) Buy $4 Maxim August 12, 2025
 
 
 
Podcast Logo
Small Stocks, Big Money™ Podcast
The podcast features in-depth interviews with CEO's from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
Available on:
Amazon Music Apple Podcasts Spotify
LEARN MORE
 
 
Upcoming Events
 
 
11
 
 
Feb 2026
 
Nexalin Technology (NASDAQ: NXL)
4:15pm Eastern
 
Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic.
 
 
 
 
 
 
 
17
 
 
Feb 2026
 
Bimergen Energy (OTCQB: BESS)
4:15pm Eastern
 
Bimergen Energy Corporation is a publicly traded independent power provider and project developer focused on utility-scale battery energy storage systems (BESS) assets.
 
 
 
 
 
 
 
Archived Events
 
 
4
 
 
FEB 2026
 
Fintech & DATS Virtual Investor Conference
4:15pm Eastern
 
The evolution of financial technology is reshaping how money moves, how value is stored, and how institutions manage digital assets. From modern payment infrastructure and embedded finance to secure custody, tokenization, and enterprise-grade digital asset management, fintech innovation is creating some of the most compelling investment opportunities in today’s markets.
 
 
 
 
 
 
 
3
 
 
FEB 2026
 
ProPhase Labs (OTC: PRPH)
4:15pm Eastern
 
ProPhase Labs Inc. (OTC: PRPH) (“ProPhase”) is a next-generation biotech, genomics and consumer products company. Our mission is to build a healthier world through bold innovation and actionable insight.
 
 
 
 
 
 
Quote of the Week
 
" An investment in knowledge pays the best interest "
— Benjamin Franklin
 
 
Order "Small Stocks, Big Money™ Today!
 
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
 
 
 
 
 
 
 
Lesson of the Week
 
Dollar cost averaging is one way to combat the volatility in small-caps.